Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushNew Insights into the Crossroads between EMT and Stemness in the Context of CancerLong non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasisEpithelial plasticity in urothelial carcinoma: Current advancements and future challengesCircular RNA participates in the carcinogenesis and the malignant behavior of cancer.The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulationProfiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer.Research advances in HMGN5 and cancer.SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer.MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer.Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.Approaches for targeting cancer stem cells drug resistance.Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.Relationship between miR-21 and miR-182 levels in peripheral blood and gastric cancer tissue.Emerging role of microRNAs in cancer stem cells: Implications in cancer therapyEpithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerEpithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistanceEnhanced functional properties of human limbal stem cells by inhibition of the miR-31/FIH-1/P21 axis.MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.Epithelial plasticity and metastatic cascade.Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-initiating Cells from Lung Adenocarcinoma.CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
P2860
Q26741215-13329D59-6230-4D9C-8425-1931888A72A8Q26764831-18D805FA-9595-4BCC-8296-A7E67473FA46Q28066271-C69F4564-0EB3-4C22-BD76-96AF6DAE5D7FQ28066321-977A0920-4B31-4682-A1B5-6DAA7D2FB693Q33739727-C0BC7C88-ED81-4FD8-A2F6-097D6A2696F4Q33907274-EB7E7E02-88AD-4611-82EB-50E570E0903AQ37687600-F1C35B9A-2B93-4C93-8BAB-DFFD837ED22FQ38678181-0C677F5A-D686-4934-BF5C-C2D1EBDA3429Q38792830-046C29C9-3DB6-4D49-8D72-D5DCED5C08E4Q38811818-18D73F25-1E11-4735-A0EE-7B420B69A071Q38833027-91C206AD-C28C-4702-99FC-379B9D917945Q38838174-3472ED93-3FFD-4AA8-A499-CFCA1DD9460DQ38909048-66CCCB45-DC36-40B0-88B0-9523456D5189Q38940586-2E93D39D-4AAF-4358-8268-3B4224E493CEQ38971795-EC022348-3649-426F-A1FE-E96D1DEA5282Q39425138-E275CA72-A993-47AE-8BD3-6B7B2D6FD703Q41143010-BC1F7E52-C006-4F51-B737-9A77FEB735B6Q41457379-C149FB75-621C-46A8-8F85-AC65E375468BQ41552614-EFD7B3F9-B18F-4A0C-8313-54C8D9BC1620Q41608178-069D282A-6EBD-462E-AA4E-2F688BDB3669Q46344495-F6A265F5-3190-4EAB-A83C-90EB0026EA00Q48628136-E4E88446-0E58-457F-80D3-54F36594F784Q49714352-423C2A4F-9D79-4BE5-ABD8-D83FFA4628F4Q49884887-BBBB9E55-D573-4313-AB6F-9E0514F177ABQ50057521-04A00FFC-7022-4547-96A0-37A3DE944F0CQ50449883-AAC74FDF-9C62-4652-9E33-F3D01C630660Q50998090-6571E206-5D1F-4C05-82ED-8DDC55BC4E50Q52714520-2B666B99-DCBF-4924-B6A3-1CCE9D4970C1Q58697956-307127DD-293F-46A5-B55B-54328EE3DDB0
P2860
Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting microRNAs in epithel ...... rapeutic approaches in cancer.
@en
type
label
Targeting microRNAs in epithel ...... rapeutic approaches in cancer.
@en
prefLabel
Targeting microRNAs in epithel ...... rapeutic approaches in cancer.
@en
P2860
P1476
Targeting microRNAs in epithel ...... rapeutic approaches in cancer.
@en
P2093
Minal Garg
P2860
P304
P356
10.1517/14728222.2014.975794
P407
P577
2015-01-07T00:00:00Z